Outcome of adults with acute lymphocytic leukemia after second salvage therapy (Q42933654)

11 November 2017

Outcome of adults with acute lymphocytic leukemia after second salvage therapy (English)

1 reference

acute lymphocytic leukemia

11 November 2017

0 references

1 reference

1 reference

9

Hagop M Kantarjian

1 reference

11 November 2017

4

Stefan Faderl

1 reference

11 November 2017

5

Jorge Cortes

1 reference

11 November 2017

1

Susan O'Brien

1 reference

11 November 2017

3

Farhad Ravandi

1 reference

11 November 2017

7

Sherry Pierce

1 reference

11 November 2017

Guillermo Garcia-Manero

series ordinal

8

object named as

Guillermo Garcia-Manero

1 reference

11 November 2017

Deborah Thomas

2

1 reference

11 November 2017

Gautum Borthakur

series ordinal

6

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

11 November 2017

1 reference

11 November 2017

113

1 reference

11 November 2017

11

1 reference

11 November 2017

3186-3191

1 reference

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Clofarabine for the treatment of acute lymphoblastic leukemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

The biology and therapy of adult acute lymphoblastic leukemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Salvage therapy for refractory or relapsed acute lymphocytic leukemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

The Medical Research Council trials in adult acute lymphocytic leukemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL).

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4188532

Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy

16 August 2018

1 reference

12 December 2020

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

12 December 2020

The importance of an isolated central nervous system relapse in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

12 December 2020

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy

1 reference

12 December 2020

Acute lymphoblastic leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.23919

1 reference

11 November 2017

1 reference

11 November 2017

1 reference